1,3-dipropyl-8-cyclopentylxanthine has been researched along with n-formylmethionine leucyl-phenylalanine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arfors, KE; Bardenheuer, HJ; Chambers, JD; Chouker, A; Fischer, S; Peter, K; Thiel, M; Zourelidis, C | 1 |
| Dubey, RK; Forman, MB; Jackson, EK; Murray, JJ; Velasco, CE; Vitola, JV | 1 |
2 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and n-formylmethionine leucyl-phenylalanine
| Article | Year |
|---|---|
Effect of adenosine on the expression of beta(2) integrins and L-selectin of human polymorphonuclear leukocytes in vitro.
Topics: 2-Chloroadenosine; Adenosine; CD18 Antigens; Dipyridamole; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; L-Selectin; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Receptors, Purinergic P1; Xanthines | 1996 |
Sustained reduction in myocardial reperfusion injury with an adenosine receptor antagonist: possible role of the neutrophil chemoattractant response.
Topics: Animals; Coronary Circulation; Dogs; Female; Male; Myocardial Reperfusion Injury; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Purinergic P1 Receptor Antagonists; Xanthines | 2000 |